Notably, the depletion of either CD4+ or CD8+ T cells significantly compromised the efficacy of anti-PD-1 therapy, highlighting the critical role of SFB-induced CD4+ T cells in facilitating the maturation and function of cytotoxic CD8+ T cells within the tumor. This evidence concerns the gene CD8A and neoplasm.